The African Group, at a key meeting of the Convention on Biological Diversity (CBD), has expressed deep regret that because of the virtual setting, representation from the African Parties has been extremely limited. […]
|
||||||
|
The CBD’s Subsidiary Body on Implementation (SBI) held a virtual informal session from 8-12 March and 14 March 2021, covering various aspects related to the implementation of the Convention and its Cartagena and Nagoya Protocols. […] The CBD’s Subsidiary Body on Scientific, Technical and Technological advice is currently holding a virtual informal session (17-19 and 24-26 February 2021). Among the agenda items discussed were that of synthetic biology, and risk assessment and risk management of LMOs. The issue of gene drive organisms features prominently in both these agenda items, with civil society calling for a moratorium on environmental releases of such organisms. […] Amidst recent scientific reports highlighting the biodiversity crisis, new negotiations have begun for crucial implementation of the CBD in the period post-2020. […] Parties to the CBD have approved conflicts of interest procedures to limit the influence of private sector industry and other economic and vested interests from unduly influencing decisions taken to protect biological diversity. […] Parties to the CBD have concluded that the rapid and fast-paced developments in the field of synthetic biology and their potential adverse effects need to be anticipated, monitored and assessed. […] Parties to the CBD have laid down strict and precautionary conditions for any introduction of organisms containing engineered gene drives into the environment, including for experimental purposes. […] Parties to the Convention on Biological Diversity have made a significant global decision on how to govern a high-risk, new genetic engineering technology – gene drives. […] Over the past 25 years, the UN Convention on Biological Diversity (CBD) has established a system of global oversight for living (a.k.a. genetically) modified organisms (LMOs) based on the principles of precaution, fairness (equitable sharing of benefits) and prior informed consent. COP 14 and COP-MOP 9 will be key to upholding those principles and ensuring they are extended to the governance of next-generation genetic engineering technologies: i.e., synthetic biology, which increasingly encompasses genome editing and gene drive technologies. […] Discussions at a subsidiary meeting of the Convention on Biological Diversity (CBD) unravelled spectacularly on the issue of sequence information of genetic resources. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||